Moleculin Biotech (MBRX) Accounts Payables (2015 - 2026)
Moleculin Biotech's Accounts Payables came in at $4.34 million for Q2 2026, up 16.6% from $3.72 million a year earlier.
Powered by 
Analysis
Moleculin Biotech (MBRX) Accounts Payables (2015 - 2026) Analysis & Trends
At the end of FY2025, Moleculin Biotech's Accounts Payables was $3.51 million, up 72.8% from FY2024.
- Accounts Payables carries a five-year compound annual growth rate of 25.5% (FY2020 to FY2025).
- Going back by year, Accounts Payables was $2.03 million in FY2024 (-18.7%), $2.5 million in FY2023 (+19.2%), $2.1 million in FY2022 (+53.6%) and $1.36 million in FY2021 (+20.8%).
- The Q2 2026 figure represents the highest quarterly Accounts Payables in data going back to Q4 2015.
- Year-over-year, Accounts Payables increased in five of the last seven quarters, with growth averaging 20.1%.
- The fastest year-over-year change in Accounts Payables over five years came in Q3 2022 (growth of 156.7%), and the weakest in Q3 2023 (a decline of 43.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Moleculin Biotech | 2.84 Mn | 2.84 Mn | - | 4.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.34 Mn |
| Dec 31, 2025 | 3.51 Mn |
| Sep 30, 2025 | 2.12 Mn |
| Jun 30, 2025 | 3.72 Mn |
| Mar 31, 2025 | 2.71 Mn |
| Dec 31, 2024 | 2.03 Mn |
| Sep 30, 2024 | 2.55 Mn |
| Jun 30, 2024 | 2.83 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | 2.50 Mn |
| Sep 30, 2023 | 2.01 Mn |
| Jun 30, 2023 | 4.14 Mn |
| Mar 31, 2023 | 1.94 Mn |
| Dec 31, 2022 | 2.10 Mn |
| Sep 30, 2022 | 3.57 Mn |
| Jun 30, 2022 | 3.18 Mn |
| Mar 31, 2022 | 2.22 Mn |
| Dec 31, 2021 | 1.36 Mn |
| Sep 30, 2021 | 1.39 Mn |
| Jun 30, 2021 | 1.51 Mn |
API Access
Moleculin Biotech Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();